{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Novavax, Inc."},"Symbol":{"label":"Symbol","value":"NVAX"},"Address":{"label":"Address","value":"21 FIRSTFIELD ROAD, GAITHERSBURG, Maryland, 20878, United States"},"Phone":{"label":"Phone","value":"+1 240 268-2000"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population."},"CompanyUrl":{"label":"Company Url","value":"https://www.novavax.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Biegie Lee","title":"Chief Information Officer & Senior Vice President"},{"name":"Gale E. Smith","title":"Chief Scientist & Senior Vice President-Discovery"},{"name":"John C.s Jacobs","title":"Co-President, Chief Executive Officer & Director"},{"name":"John J. Trizzino","title":"Co-President & Co-Chief Operating Officer"},{"name":"Raburn Mallory","title":"Senior Vice President-Clinical Development"},{"name":"Ruxandra Draghia Akli","title":"EVP & Head-Research & Development"},{"name":"Seth Toback","title":"Senior Vice President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}